Published by Iain Gilbert on 7th October 2024
(Sharecast News) - Drugmaker AstraZeneca has entered into an exclusive license agreement with CSPC Pharmaceutical to advance the development of a pre-clinical novel lipid-lowering therapy.
URL: http://www.digitallook.com/dl/news/story/34605972/...